 SEATTLE, March 02, 2022 GLOBE NEWSWIRE -- Adaptive Biotechnologies Corporation Adaptive Biotechnologies Nasdaq: ADPT, a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating virtually in the upcoming 42nd Annual Cowen Healthcare Conference. 